S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Home
Investing
ETFs
USA
NASDAQ
Direxion Shares ETF Trust Direxion Daily TSLA Bear 1X ETF (TSLS)
Direxion Shares ETF Trust Direxion Daily TSLA Bear 1X ETF (TSLS) Options

Direxion Shares ETF Trust Direxion Daily TSLA Bear 1X ETF (TSLS)

57.12

-0.56

(-0.97%)

Closed June 27 3:00PM

56.9748

-0.1452

(-0.25%)

After Hours: 6:59PM

Direxion Shares ETF Trust Direxion Daily TSLA Bear 1X ETF (TSLS) Options

TSLS Options Flow

Calls

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
47.00	8.90	11.00	0.00	9.95	0.00	0.00 %	0	0	-
48.00	8.10	10.00	0.00	9.05	0.00	0.00 %	0	0	-
49.00	7.00	9.00	0.00	8.00	0.00	0.00 %	0	0	-
50.00	6.10	8.10	7.13	7.10	0.00	0.00 %	0	1	-
51.00	5.20	7.20	6.83	6.20	0.00	0.00 %	0	1	-
52.00	4.50	6.20	0.00	5.35	0.00	0.00 %	0	0	-
53.00	3.60	5.40	4.45	4.50	0.00	0.00 %	0	1	-
54.00	2.90	4.70	0.00	3.80	0.00	0.00 %	0	0	-
55.00	2.45	3.90	4.20	3.175	0.00	0.00 %	0	3	-
56.00	1.90	3.50	3.70	2.70	0.00	0.00 %	0	19	-
57.00	1.55	2.85	2.30	2.20	0.00	0.00 %	0	2	-
58.00	1.00	2.65	1.66	1.825	0.00	0.00 %	0	3	-
59.00	0.45	2.35	1.44	1.40	0.00	0.00 %	0	2	-
60.00	0.45	2.10	1.30	1.275	0.00	0.00 %	0	8	-
61.00	0.25	1.85	1.25	1.05	0.00	0.00 %	0	7	-
62.00	0.15	1.65	0.90	0.90	0.00	0.00 %	0	3	-
65.00	0.30	1.30	0.55	0.80	0.00	0.00 %	0	3	-

Professional-Grade Tools, for Individual Investors.

Premium

Puts

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
47.00	0.00	1.10	1.35	1.35	0.00	0.00 %	0	4	-
48.00	0.00	1.15	0.00	0.00	0.00	0.00 %	0	0	-
49.00	0.00	1.25	0.00	0.00	0.00	0.00 %	0	0	-
50.00	0.00	1.30	1.40	1.40	0.00	0.00 %	0	20	-
51.00	0.05	1.40	1.71	0.725	0.00	0.00 %	0	1	-
52.00	0.10	1.60	0.00	0.85	0.00	0.00 %	0	0	-
53.00	0.05	1.75	0.00	0.90	0.00	0.00 %	0	0	-
54.00	0.20	2.05	0.00	1.125	0.00	0.00 %	0	0	-
55.00	0.90	2.25	0.00	1.575	0.00	0.00 %	0	0	-
56.00	1.40	2.85	1.50	2.125	-0.51	-25.37 %	6	6	6/26/2026
57.00	1.90	3.40	0.00	2.65	0.00	0.00 %	0	0	-
58.00	2.40	4.00	2.95	3.20	0.00	0.00 %	0	1	-
59.00	3.10	4.60	3.00	3.85	0.00	0.00 %	0	0	-
60.00	3.70	5.30	0.00	4.50	0.00	0.00 %	0	0	-
61.00	4.30	6.00	0.00	5.15	0.00	0.00 %	0	0	-
62.00	5.10	6.90	0.00	6.00	0.00	0.00 %	0	0	-
65.00	7.60	9.60	12.60	8.60	0.00	0.00 %	0	30	-

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
SDOTSadot Group Inc	US$ 20.93 (238.67%)	45.35M
PCLAPicoCELA Inc	US$ 6.591 (114.69%)	7.43M
IVFINVO Fertility Inc	US$ 2.44 (96.77%)	115.64M
WSHPWeShop Holdings Ltd	US$ 7.85 (66.67%)	8.28M
INLFINLIF Limited	US$ 0.0462 (54.00%)	2.27B
PSIGPS International Group Ltd	US$ 1.52 (-87.12%)	19.32M
CELZCreative Medical Technology Holdings Inc	US$ 1.184 (-41.67%)	552.45k
LICNLichen International Ltd	US$ 1.02 (-38.92%)	15.6M
BTCTBTC Digital Ltd	US$ 0.7212 (-36.74%)	1.46M
BEGLeverage Shares 2X Long BE Daily ETF	US$ 59.86 (-36.06%)	274.83k
INLFINLIF Limited	US$ 0.0462 (54.00%)	2.27B
GDCGD Culture Group Ltd	US$ 0.01085 (-20.80%)	520.95M
RCTRedCloud Holdings PLC	US$ 0.344 (21.60%)	267.55M
AAPLApple Inc	US$ 283.78 (3.14%)	261.95M
AMZNAmazon.com Inc	US$ 232.69 (2.50%)	248.53M

The-Shadow

The-Shadow 4 minutes ago

The 2013–2015 Inflection Point: During this specific window, the global video distribution landscape was in a state of high transition. The industry was moving toward 4K and specialized high-fidelity streaming, but the hardware decoding ecosystems for standard formats were not yet entirely locked do

BBANBOB

BBANBOB 4 minutes ago

Just get us our FCNCA stock and we will figure out what too do with it SELL It or HOLD IT

Wallstreeter$$$

Wallstreeter$$$ 8 minutes ago

And hw many of those before were prepped and submitted by Smith of Hogan Lovells!?.....oh right the ans is zero! Pretty sure he knows a whole lot more abt what the FDA wants compared to MK just winging it in the past.

brooktrail1933

brooktrail1933 9 minutes ago

Of course they could, but here's the quote from Beartrap:

"IMHO, the real question now is will Dr. Bosch release the decision on the MAA at this presentation?"

mm41

mm41 11 minutes ago

Introductory Macroeconomic Overview
When WE published our preliminary reviews of NVIDIA Corporation (Ticker: NVDA) in April and May 2026, our primary objective was to expose the superficiality of the consensus market narrative. Today, in late June 2026, as market euphoria is mechanically sust

namtae

namtae 12 minutes ago

How many shares did you top off in the 70s and 80's?

Must be quite a bit according to your posting history

learningcurve2020

learningcurve2020 12 minutes ago

All the PLD data in the world isn’t going to tell them why L worked on a small number of patients. LP was likely told to figure that out first then resume trials. That’s also why LL became a SA. Without that information, another trial, and combined with reasonable cost, UK Marketing approval at th

capgain

capgain 12 minutes ago

Same here, and what a great price! He sure seems like it.

walterc

walterc 13 minutes ago

they were accumulated over severall weeks by the market makers

mm41

mm41 14 minutes ago

Calling this 'fear-based' is a convenient way to dismiss a forensic balance sheet analysis. You’re trading off consensus narratives; I’m trading off what’s actually recorded in the filings. Let’s address your 'scrutiny':

On Receivables & Cash Flow: You claim DSO is 'stable' and 'no ve

BIOChecker4

BIOChecker4 17 minutes ago

Right, and Ern and the 70 other AD patients you claim are still alive and taking Blarcamesine every day even though the compassionate use program ended in 2024. Are these folks mixing their own batches of Blarcamesine in Ern’s basement?

Doc logic

Doc logic 17 minutes ago

brazen22,

Thank you for supplying that direct quote. Again, “authorities” is plural so the warning is warranted because FDA only “accepts” the SAP hence the caution that one or more of those “authorities” may not grant product APPROVAL based on that approach. This statement covers t

BBANBOB

BBANBOB 18 minutes ago

Could go on forever but I seriously doubt that it will

DA BOYZ which have enough money to seriously stir the POT want their money as well

Wallstreeter$$$

Wallstreeter$$$ 19 minutes ago

Anyone.....has the company ever indicated they're looking at uplisting?

BBANBOB

BBANBOB 20 minutes ago

I have said on multiple occasions here that IF none OF THE dates PRODUCE ANYTHING, then I will wait for closing of the "R" before I make any decisions as to if anything is or IS NOT coming back.
CBOA( indicated that we MAY VERY WELL HAVE TO WAIT for the "R" to be lifted before anything takes

theswordman

theswordman 20 minutes ago

Apologies. Do you find Hoffman is not doing as well as micky mouse mulholland and sidekick weed/wine.??

The 3 rounds of financing were linked .
So for #1-- Did you not like the Yorkville deal because of there are no warrants, derivatives, or other share classes asso

flipper44

flipper44 21 minutes ago

Scientific analysis with patient level data is not a distraction. If you can’t follow, spend that upcoming half hour on your rowing machine.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177739827

SSKILLZ1

SSKILLZ1 21 minutes ago

Pick 4 Contest #24 Contest Week 6 Results In

Hope everyone enjoys the stats and has fun in the contest. Hope this helps.

https://investorshub.advfn.com/Pick-4-Contest-No-24-50633

NotTheRealBeeny

NotTheRealBeeny 21 minutes ago

I bet that's true of the others that recently showed up as well. They'll all disappear at the same time too. I'm sure it's coincidence.

SSKILLZ1

SSKILLZ1 22 minutes ago

Pick 4 Contest #24 Contest Week 6 Results In

Hope everyone enjoys the stats and has fun in the contest. Hope this helps.

https://investorshub.advfn.com/Pick-4-Contest-No-24-50633

biotechinvestor1

biotechinvestor1 22 minutes ago

I agree. The sooner the better. Also while they are at it, they should replace the VP of IR who came from Antares. In over 30 years of experience as an investor in biopharma, I have not seen one with such poor performance.

Wallstreeter$$$

Wallstreeter$$$ 23 minutes ago

Have to agree with you on that one. Its very possible IDE approval may not have a huge effect on the PPS, but....if the right peeps hop onboard it could get real crazy on news. I guess w'ell see soon enuf.

ZZZ888

ZZZ888 24 minutes ago

gitreal

gitreal 24 minutes ago

He does it as a public service. Purely voluntary! Except for the free shares.

murrayhill

murrayhill 25 minutes ago

The Tokai "335" caught my eye;
that first guy was a guitar player, imo.

Direxion Shares ETF Trus...

Spirit Blockchain Capital

Peppermint Innovation

1.625% 15nov2027 1.625% ...

First Trust Lunt Us Fact...

Diversified Royalty

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN

Already have an account? Sign in

Don't have an account? Sign up

By registering, I confirm I have read, understand, and agree to ADVFN's Terms and Conditions and that I am a private investor.